325 related articles for article (PubMed ID: 25713800)
1. Hepatitis B virus large surface protein: function and fame.
Churin Y; Roderfeld M; Roeb E
Hepatobiliary Surg Nutr; 2015 Feb; 4(1):1-10. PubMed ID: 25713800
[TBL] [Abstract][Full Text] [Related]
2. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
[TBL] [Abstract][Full Text] [Related]
3. Association of the Hepatitis B Virus Large Surface Protein with Viral Infectivity and Endoplasmic Reticulum Stress-mediated Liver Carcinogenesis.
Lin WL; Hung JH; Huang W
Cells; 2020 Sep; 9(9):. PubMed ID: 32911838
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus large surface protein is priming for hepatocellular carcinoma development via induction of cytokinesis failure.
Musa J; Li J; Grünewald TG
J Pathol; 2019 Jan; 247(1):6-8. PubMed ID: 30246253
[TBL] [Abstract][Full Text] [Related]
5. Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver.
Nakabori T; Hikita H; Murai K; Nozaki Y; Kai Y; Makino Y; Saito Y; Tanaka S; Wada H; Eguchi H; Takahashi T; Suemizu H; Sakamori R; Hiramatsu N; Tatsumi T; Takehara T
Sci Rep; 2016 Jun; 6():27782. PubMed ID: 27278060
[TBL] [Abstract][Full Text] [Related]
6. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes.
Lempp FA; Wiedtke E; Qu B; Roques P; Chemin I; Vondran FWR; Le Grand R; Grimm D; Urban S
Hepatology; 2017 Sep; 66(3):703-716. PubMed ID: 28195359
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an
Tu T; Budzinska MA; Vondran FWR; Shackel NA; Urban S
J Virol; 2018 Jun; 92(11):. PubMed ID: 29437961
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis.
Li TN; Wu YJ; Tsai HW; Sun CP; Wu YH; Wu HL; Pei YN; Lu KY; Yen TT; Chang CW; Chan HL; Tao MH; Liou JY; Chang MD; Su IJ; Wang LH
J Pathol; 2018 Aug; 245(4):502-513. PubMed ID: 29862509
[TBL] [Abstract][Full Text] [Related]
9. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T
J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168
[TBL] [Abstract][Full Text] [Related]
10. Naturally Occurring Hepatitis B Virus Mutations Leading to Endoplasmic Reticulum Stress and Their Contribution to the Progression of Hepatocellular Carcinoma.
Choi YM; Lee SY; Kim BJ
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704071
[TBL] [Abstract][Full Text] [Related]
11. The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency.
Liu C; Xu G; Gao Z; Zhou Z; Guo G; Li D; Jing Z; Sui J; Li W
Virology; 2018 Sep; 522():168-176. PubMed ID: 30032030
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake of hepatitis B virus envelope L particles is independent of sodium taurocholate cotransporting polypeptide, but dependent on heparan sulfate proteoglycan.
Somiya M; Liu Q; Yoshimoto N; Iijima M; Tatematsu K; Nakai T; Okajima T; Kuroki K; Ueda K; Kuroda S
Virology; 2016 Oct; 497():23-32. PubMed ID: 27420796
[TBL] [Abstract][Full Text] [Related]
13. A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction.
Saso W; Tsukuda S; Ohashi H; Fukano K; Morishita R; Matsunaga S; Ohki M; Ryo A; Park SY; Suzuki R; Aizaki H; Muramatsu M; Sureau C; Wakita T; Matano T; Watashi K
Biochem Biophys Res Commun; 2018 Jun; 501(2):374-379. PubMed ID: 29730285
[TBL] [Abstract][Full Text] [Related]
14. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
Qiao L; Sui J; Luo G
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
[TBL] [Abstract][Full Text] [Related]
15. A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins.
Tsukuda S; Watashi K; Hojima T; Isogawa M; Iwamoto M; Omagari K; Suzuki R; Aizaki H; Kojima S; Sugiyama M; Saito A; Tanaka Y; Mizokami M; Sureau C; Wakita T
Hepatology; 2017 Apr; 65(4):1104-1116. PubMed ID: 27863453
[TBL] [Abstract][Full Text] [Related]
16. Multitasking Na
Zakrzewicz D; Geyer J
Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052874
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection.
Yan Y; Allweiss L; Yang D; Kang J; Wang J; Qian X; Zhang T; Liu H; Wang L; Liu S; Sui J; Chen X; Dandri M; Zhao J; Lu F
Emerg Microbes Infect; 2019; 8(1):879-894. PubMed ID: 31179847
[TBL] [Abstract][Full Text] [Related]
18. Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus.
Yan H; Li W
Dig Dis; 2015; 33(3):388-96. PubMed ID: 26045274
[TBL] [Abstract][Full Text] [Related]
19. New perspectives of biomarkers for the management of chronic hepatitis B.
Lin CL; Kao JH
Clin Mol Hepatol; 2016 Dec; 22(4):423-431. PubMed ID: 28081591
[TBL] [Abstract][Full Text] [Related]
20. Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.
Winer BY; Shirvani-Dastgerdi E; Bram Y; Sellau J; Low BE; Johnson H; Huang T; Hrebikova G; Heller B; Sharon Y; Giersch K; Gerges S; Seneca K; Pais MA; Frankel AS; Chiriboga L; Cullen J; Nahass RG; Lutgehetmann M; Toettcher JE; Wiles MV; Schwartz RE; Ploss A
Sci Transl Med; 2018 Jun; 10(447):. PubMed ID: 29950446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]